GLAXOSMITHKLINE has dropped plans to float its HIV drug business. ViiV, its joint venture with Pfizer and Japan's Shionogi, could have been valued at about £15billion but Glaxo said its decision to retain the business reflects its strong positive ... Scottish Daily Express, 3 weeks ago
GSK Cuts Return to Holders From Novartis Asset Swap - Morningstar.com, 3 weeks ago
Viiv Healthcare launches Triumeq in Japan - Pharma Letter, 1 month ago
More from: ADVFN UK, ADVFN India...and 4 other sources
Shionogi Inc. today announced data from a Phase IIb study that showed 0.2 mg and 0.4 mg of naldemedine demonstrated statistically significant efficacy in treating opioid-induced constipation (OIC) in patients with chronic non-cancer pain.News-Medical.Net, 1 week ago Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation PR Newswire, 1 week ago Shionogi, Inc. Release: Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation 5/19/2015 ClinicSpace, 1 week ago Shionogi's Phase III OIC study meets primary and secondary endpoints Individual.com, 1 month ago
STALLERGENES S.A., a biopharmaceutical company, has announced that its partner, Shionogi & Co., Ltd has received the approval from the Japanese health authorities, Pharmaceuticals and Medical Devices Agency, or PMDA, for STG320, a immunotherapy ...Individual.com, 1 month ago
Egalet Corp. received a $10 million milestone payment from Japanese pharmaceutical company Shionogi under terms of a licensing agreement the two organizations signed in 2013. The payment was triggered by Shionogi filing an investigational new drug ...Philadelphia Business Journal, 2 months ago Egalet Earns $10 Million Milestone Payment Triggered by Advancement of Shionogi's Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's Guardian Technology Wall Street Business Network, 2 months ago Egalet : Earns $10 Million Milestone Payment Triggered by Advancement of Shionogi's Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's Guardian Technology 4 Traders, 2 months ago Egalet announces business highlights, financial results for first quarter 2015 News-Medical.Net, 3 weeks ago
Shionogi : Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of...
Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist] By a News Reporter-Staff ...4 Traders, 1 week ago SHIONOGI : Data on Pharmacokinetics Reported by Researchers at Shionogi & Co. Ltd. (Using Improved Serial Blood Sampling Method of Mice to Study... 4 Traders, 2 months ago
ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative, Inc. (CHAI) announced that Aurobindo Pharma, a Rs. 8,000 crore Indian pharma major, has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for ...PharmaBiz, 2 days ago ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV National AIDS Treatment Advocacy Project, 1 hour ago Nouvelle étape pour la collaboration entre ViiV Healthcare et la CHAI avec le premier dépôt de dossier auprès de la FDA par Aurobindo Pharma pour le dolutégravir générique pour le traitement du VIH Africa News Wire, 3 days ago ViiV Healthcare And Collaboration Delivers Second Milestone With First Filing With The FDA Of Generic Dolutegravir By Aurobindo Pharma For The Treatment Of HIV BioSpace, 3 days ago
Asian stock markets are mostly in negative territory on Wednesday, tracking the weak lead overnight from Wall Street as upbeat U.S. economic data overnight spurred concerns of an interest rate hike sooner rather than later. Additionally, a stronger ...RTTNews.com, 3 days ago Asian Markets Mostly Higher London South East, 1 month ago
The Japanese stock market is marginally lower on Wednesday, following the negative cues overnight from Wall Street and as investors resorted to profit taking after eight straight days of gains. In late-morning trades, the benchmark Nikkei 225 Index ...RTTNews.com, 3 days ago Japanese Market Drifts Lower In Choppy Trade RTTNews.com, 1 month ago
Japan stocks were higher after the close on Tuesday, as gains in the Transport, Paper & Pulp and Fishery sectors led shares higher. At the close in Tokyo, the Nikkei 225 rose 0.12% to hit a new all time high. The best performers of the session ...Investing.com, 3 days ago Japanese Stocks Swing as Energy Shares Rise, Drug Makers Drop La Repubblica, 1 month ago Japanese Stocks Fall as Yen Strengthens After U.S. Retail Sales La Repubblica, 1 month ago
Healthy mothers and children are frequently colonized with pathogenic Escherichia coli that are resistant to ciprofloxacin as well as multiple additional antibiotics, researchers have found. The identified strain of E coli was similar to human ...Dermatology Online Journal, 4 days ago
on your WebpageAdd Widget >Get your members hooked!